Skip to content

Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients

Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01034150
Enrollment
20
Registered
2009-12-17
Start date
2007-12-31
Completion date
2009-11-30
Last updated
2009-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Objective: To investigate effects of home-based somatosensory stimulation associated with motor training on improvement in performance of the paretic upper extremity in patients in the chronic phase after stroke.

Detailed description

Design: Double-blind, randomized, controlled clinical trial. Setting: Home-based rehabilitation. Subjects: Patients in the chronic phase (\> 6 months) after stroke. Interventions: Patients will be randomized to an active and a control group. In both groups, treatments will be performed at home, daily, over four weeks. Patients in the active group will be instructed to use a device that provides somatosensory stimulation in the form of electrical stimulation of the median nerve for two hours. Patients in the control group will also be instructed to use the device for two hours, and sham stimulation will be administered. In both groups, patients will be instructed to train activities with the paretic hand immediately after nerve stimulation. Main measures: The primary outcome will be improvement in performance of the paretic hand evaluated by the Jebsen-Taylor test at end of treatment and four months after end of treatment, compared to baseline. Secondary outcomes were: 1) Compliance with the interventions, assessed through a daily written log, and oral reports of the patients; 2) safety profile of the interventions.

Interventions

DEVICERelief band (Somatosensory stimulation)

Electrical median nerve stimulation

Placebo stimulation

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age 18-80 years; * single ischemic or hemorrhagic stroke in a cerebral hemisphere, documented by computed tomography (CT) or magnetic resonance imaging (MRI); * stroke onset at least six months before; * hand paresis with preserved ability to perform all tasks of the Jebsen-Taylor Test (JTT).

Exclusion criteria

* previous strokes; * epilepsy and other neurological conditions; * proprioceptive or tactile anesthesia; * shoulder or hand pain; * severe joint deformity; * severe chronic disease; * inability to give provide informed consent due to severe aphasia or cognitive impairment; * left handedness before the stroke.

Design outcomes

Primary

MeasureTime frame
the improvement in upper extremity performance assessed using Jebsen-Taylor testTreatment lasted four weeks. Measures were performed before the treatment, immediately after the treatment and four months after the end of the treatment

Secondary

MeasureTime frame
Compliance with the interventions, assessed through a daily written log, and oral reports of the patientsimmediately after the treatment
Adverse eventsat end of treatment

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026